コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 et of hypoxia-inducible factor 1 (Hif-1) and peroxisome proliferator-activated receptors.
2 mediated lipolysis to induce the activity of peroxisome proliferator-activated receptors.
3 to a putatively advantageous allele for the peroxisome proliferator-activated receptor A (PPARA) gen
4 Across drug classes, risk was highest with peroxisome proliferator-activated receptor agonists (RR
5 e glutathione-S-transferase 4-4 (Gsta4(-/-))/peroxisome proliferator activated receptor alpha (Ppara(
6 esponsive element binding protein 1 (CREB1), peroxisome proliferator activated receptor alpha (PPARA)
7 t increased the Gpat4(-/-) BAT expression of peroxisome proliferator-activated receptor alpha (PPAR)
9 receptor type 1 (CB1) or type 2 (CB2) or via peroxisome proliferator-activated receptor alpha (PPAR-a
10 adipocytes by controlling the expression of peroxisome proliferator-activated receptor alpha (Ppara)
11 such as bezafibrate, known activators of the peroxisome proliferator-activated receptor alpha (PPARal
12 ific DRE that overlaps binding sequences for peroxisome proliferator-activated receptor alpha (PPARal
14 atoma FAO cells with Wy14,643, an agonist of peroxisome proliferator-activated receptor alpha (PPARal
16 phosphorylates serine 73 (Ser(P)(73)) of the peroxisome proliferator-activated receptor alpha (PPARal
18 he interaction and synergy between CREBH and peroxisome proliferator-activated receptor alpha (PPARal
20 higher activity of the androgen-induced gene peroxisome proliferator-activated receptor alpha (PPARal
21 tanoic acid (PFOA) increases mouse and human peroxisome proliferator-activated receptor alpha (PPARal
23 id-lowering drug and a potent agonist of the peroxisome proliferator-activated receptor alpha (PPARal
24 gen species (ROS) activate ligand binding to peroxisome proliferator-activated receptor alpha (PPARal
26 genes in concert with reduced signaling via peroxisome proliferator-activated receptor alpha (PPARal
27 and stabilizes the ligand-binding domain of peroxisome proliferator-activated receptor alpha (PPARal
29 n, Acot1 knockdown reduced the expression of peroxisome proliferator-activated receptor alpha (PPARal
30 igated whether Astragaloside IV can activate peroxisome proliferator-activated receptor alpha (PPARal
31 ecular analysis unraveled that inhibition of peroxisome proliferator-activated receptor alpha activit
32 interacts with the hepatic nuclear receptors peroxisome proliferator-activated receptor alpha and liv
33 that pressure overload induced decreases in peroxisome proliferator-activated receptor alpha and unc
34 also observed, and we provide evidence that peroxisome proliferator-activated receptor alpha is cons
35 gene is an AMP-activated protein kinase and peroxisome proliferator-activated receptor alpha respons
37 Falpha (3.0-fold), whereas the expression of peroxisome proliferator-activated receptor alpha target
38 al target of the nuclear receptor PPARalpha (peroxisome proliferator-activated receptor alpha) in bot
41 ment binding protein-hepatocyte specific and peroxisome proliferator-activated receptor alpha, which
44 ect of PERC on bodyweight loss, induction of peroxisome proliferator activated receptor-alpha (PPARal
46 ing fatty acid beta-oxidation with GW7647, a peroxisome proliferator-activated receptor-alpha (PPARal
47 insulin and mTORC1 signaling was activated, peroxisome proliferator-activated receptor-alpha (PPARal
49 sepsis and to identify the mechanism whereby peroxisome proliferator-activated receptor-alpha confers
51 ant to survival in sepsis than hematopoietic peroxisome proliferator-activated receptor-alpha express
55 ared with wild-type mice irrespective of the peroxisome proliferator-activated receptor-alpha status
56 gulation of nhr-49 (an ortholog of the human peroxisome proliferator-activated receptor-alpha), and a
57 Expression of the PLIN5 gene is regulated by peroxisome proliferator-activated receptor-alpha, fastin
58 R heterodimer partners, liver X receptor and peroxisome proliferator-activated receptor-alpha, key in
59 ry compound that was recently shown to exert peroxisome proliferator-activated receptor-alpha-depende
61 mation and metabolism and are targets of the peroxisome proliferator-activated receptor and liver X r
62 ese results are consistent with induction of peroxisome proliferator-activated receptors and disrupti
63 , transient receptor potential channels, and peroxisome proliferator activated receptors are also eng
66 inked these alterations to downregulation of peroxisome proliferator-activated receptor coactivator 1
72 igand activation of the transcription factor peroxisome proliferator-activated receptor delta (PPARde
73 uscle, together with increased expression of peroxisome proliferator-activated receptor delta (PPARde
75 Moreover, FAs from higher lipolysis activate peroxisome proliferator-activated receptor delta to indu
76 elpar is a potent, selective agonist for the peroxisome proliferator-activated receptor-delta (PPAR-d
77 growth hormone secretagogue ibutamoren, the peroxisome proliferator-activated receptor-delta agonist
81 cyte fate in vivo requires activation of the peroxisome proliferator activated receptor gamma (PPARga
82 f human chorionic gonadotropin (hCGbeta) and peroxisome proliferator activated receptor gamma (PPARga
83 chain amino acids (BCAA), and regulation of peroxisome proliferator activated receptor gamma (PPARga
84 ty to activate the nuclear hormone receptor, peroxisome proliferator activated receptor gamma (PPARga
85 e dismutase, mitochondrial KATP channels and peroxisome proliferator activated receptor gamma coactiv
86 ells with and without lipid loading based on peroxisome proliferator activated receptor gamma coactiv
91 ant upregulation, in the lung mesenchyme, of peroxisome proliferator-activated receptor gamma (master
92 with markedly diminished ability to activate peroxisome proliferator-activated receptor gamma (MSDC-0
93 We studied interactions between polar bear peroxisome proliferator-activated receptor gamma (pbPPAR
94 action between OmpA and Ecgp96 downregulates peroxisome proliferator-activated receptor gamma (PPAR-g
95 restored expression of the nuclear receptor peroxisome proliferator-activated receptor gamma (PPAR-g
97 ng through the intracellular butyrate sensor peroxisome proliferator-activated receptor gamma (PPAR-g
98 CL10 and IL-6 transcript levels, and induced peroxisome proliferator-activated receptor gamma (PPAR-g
99 een in a Pten-null background, we identified peroxisome proliferator-activated receptor gamma (Pparg)
100 d their expression of a key adipogenic gene, peroxisome proliferator-activated receptor gamma (Pparg)
101 on of several of its target genes, including peroxisome proliferator-activated receptor gamma (PPARG)
103 pha), C/EBPbeta, C/EBPdelta, KLF5, KLF9, and peroxisome proliferator-activated receptor gamma (PPARga
104 d the extracellular matrix, particularly the peroxisome proliferator-activated receptor gamma (Pparga
106 lipid droplet formation and the induction of peroxisome proliferator-activated receptor gamma (PPARga
107 gh levels of TNF and IL-12 but low levels of peroxisome proliferator-activated receptor gamma (PPARga
108 anoparticle (NP) platforms to deliver either Peroxisome Proliferator-Activated Receptor gamma (PPARga
109 ative DNA binding behavior of the adipogenic peroxisome proliferator-activated receptor gamma (PPARga
110 describe here a regulatory circuit in which peroxisome proliferator-activated receptor gamma (PPARga
111 y activation of the nuclear hormone receptor peroxisome proliferator-activated receptor gamma (PPARga
115 their direct action on the nuclear receptor peroxisome proliferator-activated receptor gamma (PPARga
116 ich was recruited to the promoter of Nox1, a peroxisome proliferator-activated receptor gamma (PPARga
118 reduced by concomitant administration of the peroxisome proliferator-activated receptor gamma (PPARga
120 such as rosiglitazone and pioglitazone, are peroxisome proliferator-activated receptor gamma (PPARga
121 iated macrophage differentiation by cleaving peroxisome proliferator-activated receptor gamma (PPARga
122 element-binding protein H (CREBH) but not by peroxisome proliferator-activated receptor gamma (PPARga
123 Using mice with a conditional deletion of peroxisome proliferator-activated receptor gamma (PPARga
126 er type 4 (GLUT4), lipoprotein lipase (LpL), peroxisome proliferator-activated receptor gamma (PPARga
127 An important player in their pathogenesis is peroxisome proliferator-activated receptor gamma (PPARga
128 tion depends on interactions between Sp1 and peroxisome proliferator-activated receptor gamma (PPARga
130 miR-503 expression is directly regulated by peroxisome proliferator-activated receptor gamma (PPARga
131 und that this defect is because of defective peroxisome proliferator-activated receptor gamma (PPARga
136 ancer-binding protein alpha (C/EBPalpha) and peroxisome proliferator-activated receptor gamma (PPARga
140 ver development by suppressing expression of peroxisome proliferator-activated receptor gamma 2 and l
141 ented the inflammatory response dependent on peroxisome proliferator-activated receptor gamma activit
142 N-terminal kinase inhibitor SP600125 and the peroxisome proliferator-activated receptor gamma agonist
143 lta-prostaglandin J2-dependent activation of peroxisome proliferator-activated receptor gamma and mac
144 ated protein 2 expression and suppression of peroxisome proliferator-activated receptor gamma and p27
145 EM1, increased transcriptional activation of peroxisome proliferator-activated receptor gamma and pro
146 int of communication between the miR-130/301-peroxisome proliferator-activated receptor gamma axis in
147 s, including uncoupling protein 1 (Ucp1) and peroxisome proliferator-activated receptor gamma co-acti
151 evels and the expression of four isoforms of peroxisome proliferator-activated receptor gamma coactiv
152 chondrial transcription factor A (TFAM), and peroxisome proliferator-activated receptor gamma coactiv
153 idrug resistance-associated protein 2 and 4, peroxisome proliferator-activated receptor gamma coactiv
154 ated the role of ERK1/2 on the expression of peroxisome proliferator-activated receptor gamma coactiv
155 ets, Myc and the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactiv
156 teins FOXO1, FOXO3A, and FOXO4 and decreased peroxisome proliferator-activated receptor gamma coactiv
158 uction and ATP levels, reduced expression of peroxisome proliferator-activated receptor gamma coactiv
160 of cyclic guanosine monophosphate (cGMP) and peroxisome proliferator-activated receptor gamma coactiv
161 of p38 MAPK decreased accumulation of active peroxisome proliferator-activated receptor gamma coactiv
162 Thus, we hypothesized that overexpression of peroxisome proliferator-activated receptor gamma coactiv
164 w here that the transcriptional coactivators peroxisome proliferator-activated receptor gamma coactiv
165 steoblast apoptosis that was associated with peroxisome proliferator-activated receptor gamma coactiv
166 ough AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor gamma coactiv
167 on directly through increased translation of peroxisome proliferator-activated receptor gamma coactiv
168 nd ZR75.1 breast cancer cells, IGF-1 induces peroxisome proliferator-activated receptor gamma coactiv
169 y, which is caused by a rapid degradation of Peroxisome proliferator-activated receptor gamma Coactiv
171 Here we demonstrate, unexpectedly, that peroxisome proliferator-activated receptor gamma coactiv
172 irisin precursor) and its upstream activator peroxisome proliferator-activated receptor gamma coactiv
173 ssion, potentially through the regulation of peroxisome proliferator-activated receptor gamma coactiv
175 but was independent of the activation of the peroxisome proliferator-activated receptor gamma coactiv
176 e Huh7, the coexpression of the coactivators peroxisome proliferator-activated receptor gamma coactiv
177 city are known to regulate and interact with peroxisome proliferator-activated receptor gamma coactiv
178 gnature genes uncoupling protein (UCP)-1 and peroxisome proliferator-activated receptor gamma coactiv
179 Here we demonstrate that the coactivator peroxisome proliferator-activated receptor gamma coactiv
180 tably, the mitochondrial DNA copy number and peroxisome proliferator-activated receptor gamma coactiv
181 ouse, these UCP1(+) cells also expressed the peroxisome proliferator-activated receptor gamma coactiv
183 on of Zfp423, a transcriptional regulator of peroxisome proliferator-activated receptor gamma express
184 that fuses paired box gene 8 (PAX8) with the peroxisome proliferator-activated receptor gamma gene (P
185 CBD enhanced the transcriptional activity of peroxisome proliferator-activated receptor gamma in luci
186 nase 2, 15-deoxy Delta-prostaglandin J2, and peroxisome proliferator-activated receptor gamma in this
188 BPD that is not dependent on the decrease in peroxisome proliferator-activated receptor gamma levels.
190 nsport, possibly through oxidized fatty acid peroxisome proliferator-activated receptor gamma ligands
191 vo, that miR-130/301-specific control of the peroxisome proliferator-activated receptor gamma regulat
192 c-Jun N-terminal kinase, thereby inhibiting peroxisome proliferator-activated receptor gamma through
194 has shown that phosphorylation of PPARgamma (peroxisome proliferator-activated receptor gamma) at ser
196 ing STAT3, STAT6, Kruppel-like factor 4, and peroxisome proliferator-activated receptor gamma, and ca
197 he mitochondrial transcriptional coactivator peroxisome proliferator-activated receptor gamma, coacti
198 nd import of the transcriptional coactivator peroxisome proliferator-activated receptor gamma-coactiv
199 tochondrial biogenesis regulator Pgc-1alpha (peroxisome proliferator-activated receptor gamma-coactiv
200 gulating macrophage lipid metabolism through peroxisome proliferator-activated receptor gamma-depende
201 e injections in rats were reported to induce peroxisome proliferator-activated receptor gamma-depende
207 phosphatases, and ameliorated activation of peroxisome proliferator-activated receptor gamma/sterol
208 ificant alterations in pathways regulated by peroxisome proliferator activated receptor-gamma (PPARga
210 wk with rosiglitazone, a specific agonist of peroxisome proliferator-activated receptor-gamma (PPAR-g
211 the upregulation of the transcription factor peroxisome proliferator-activated receptor-gamma (PPAR-g
213 reduced food intake and altered signaling by peroxisome proliferator-activated receptor-gamma (PPAR-g
214 n primary cultures, 2) likewise blocked by a peroxisome proliferator-activated receptor-gamma (PPAR-g
215 and transcription of ABCG1 and ABCA1 through peroxisome proliferator-activated receptor-gamma (PPARG)
216 d patients with NAFLD, hepatic expression of peroxisome proliferator-activated receptor-gamma (PPARG)
218 but improvement of insulin resistance using peroxisome proliferator-activated receptor-gamma (PPARga
219 al interactions between prenatal DHA and the peroxisome proliferator-activated receptor-gamma (PPARga
220 X receptors alpha and beta (LXRalpha,beta), peroxisome proliferator-activated receptor-gamma (PPARga
221 ctor for transcription factors including the peroxisome proliferator-activated receptor-gamma (PPARga
222 nes, antidiabetic drugs that are agonists of peroxisome proliferator-activated receptor-gamma (PPARga
224 Here we show that dietary SCFAs induce a peroxisome proliferator-activated receptor-gamma (PPARga
225 D challenge revealed that the mRNA levels of peroxisome proliferator-activated receptor-gamma (PPARga
226 13.1 treatment were associated with enhanced peroxisome proliferator-activated receptor-gamma (PPARga
227 ented and even partially reversed ex vivo by peroxisome proliferator-activated receptor-gamma agonist
229 a healthy human (mini-)organ, and show that peroxisome proliferator-activated receptor-gamma agonist
232 ung protein showed significant reductions in peroxisome proliferator-activated receptor-gamma and CD3
233 on the transcription coactivator PGC-1beta (peroxisome proliferator-activated receptor-gamma co-acti
234 cal exercise and thyroid hormone mediate the peroxisome proliferator-activated receptor-gamma coactiv
236 n of the mitochondrial biogenesis regulators peroxisome proliferator-activated receptor-gamma coactiv
237 ctivated receptor-gamma coactivator 1-alpha, peroxisome proliferator-activated receptor-gamma coactiv
240 involving the master mitochondrial regulator peroxisome proliferator-activated receptor-gamma coactiv
241 latory proteins, and herein we identify that peroxisome proliferator-activated receptor-gamma coactiv
242 ke factor 15; myocyte enhancer factor 2, and peroxisome proliferator-activated receptor-gamma coactiv
243 d the AMP-activated protein kinase/sirtuin 1/peroxisome proliferator-activated receptor-gamma coactiv
244 mediated by the transcriptional coactivator peroxisome proliferator-activated receptor-gamma coactiv
245 -related genes and a persistent reduction in peroxisome proliferator-activated receptor-gamma express
246 pression of fatty acid binding protein 4 and peroxisome proliferator-activated receptor-gamma in adip
247 that an interaction between STAT1, p300, and peroxisome proliferator-activated receptor-gamma is requ
248 4(-/-) macrophages have relatively increased peroxisome proliferator-activated receptor-gamma levels
249 (-/-) OPCs with cholesterol or activation of peroxisome proliferator-activated receptor-gamma with pi
250 ral components of the liver clock, including peroxisome proliferator-activated receptor-gamma, coacti
251 ease of a transferable factor able to induce peroxisome proliferator-activated receptor-gamma-mediate
252 roxynonenal) released from the heart trigger peroxisome proliferator-activated receptor-gamma-mediate
253 vation of arterial NADPH oxidase triggered a peroxisome proliferator-activated receptor-gamma-mediate
254 al LPS exposure led to pre-existing elevated peroxisome proliferators-activated receptor-gamma co-act
255 Tfe3, control the regulator of adipogenesis, peroxisome proliferator-activated receptor gamma2 (Pparg
256 Adiponectin receptor agonists, selective peroxisome proliferator-activated receptor modulators, c
257 essed the hypothesis that variability in the Peroxisome Proliferator Activated Receptor (PPAR) pathwa
258 noma cells and is upregulated by agonists of peroxisome proliferator-activated receptor (PPAR) alpha
259 pregnane X receptor (PXR) [rifampicin], and peroxisome proliferator-activated receptor (PPAR) alpha
260 demonstrates that gemfibrozil, an agonist of peroxisome proliferator-activated receptor (PPAR) alpha,
261 g-mediated activation of the lipid regulator peroxisome proliferator-activated receptor (PPAR) alpha.
263 cts of A1AT-FA were blocked by inhibitors of peroxisome proliferator-activated receptor (PPAR) beta/d
264 tigated whether the nuclear hormone receptor peroxisome proliferator-activated receptor (PPAR) beta/d
266 analysis revealed that ZFP407 regulates many peroxisome proliferator-activated receptor (PPAR) gamma
269 bound by the adipocytic transcription factor peroxisome proliferator-activated receptor (PPAR) gamma,
270 f 5' AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor (PPAR), respe
271 a models, we report that CD8(+) TILs enhance peroxisome proliferator-activated receptor (PPAR)-alpha
272 nt receptor potential vanilloid (TRPV)-1 and peroxisome proliferator-activated receptor (PPAR)-alpha.
275 chanistic target of rapamycin (mTOR) and the peroxisome proliferator-activated receptor (PPAR)-gamma
277 gulates a host of target proteins, including peroxisome proliferator-activated receptor (PPAR)-gamma
279 ipogenesis (+30% Oil Red O stain [ORO], +50% peroxisome proliferator-activated receptor (PPAR)-gamma
280 oxidation is transcriptionally regulated by peroxisome proliferator-activated receptor (PPAR)alpha a
281 s developed as a highly selective inhibitory peroxisome proliferator-activated receptor (PPAR)beta/de
283 ctly interacts with the transcription factor peroxisome proliferator-activated receptor (PPAR)gamma.
284 into lipid-laden adipocytes by upregulating peroxisome proliferator-activated receptor (PPARgamma) a
286 one of the three isoforms identified for the peroxisome proliferator-activated receptors (PPARs) and
291 NRs for treating metabolic diseases are the peroxisome proliferator-activated receptors (PPARs), PPA
292 adelmidrol is dependent on the activation of peroxisome proliferator-activated receptors (PPARs), we
293 binoids are reported to have actions through peroxisome proliferator-activated receptors (PPARs), whi
294 th 14 other nuclear receptors, including the peroxisome proliferator-activated receptors (PPARs).
295 PARgamma is one of the three isoforms of the Peroxisome Proliferator-Activated Receptors (PPARs).
296 of inflammatory mediators and repression of peroxisome proliferator-activated receptor signaling and
297 n metabolic pathways, some linked to altered peroxisome proliferator-activated receptor signaling, mu
298 the first week due to failure to undergo the peroxisome proliferator-activated receptor signaling-dep
299 sed, whereas SREBP-1 interference increased, peroxisome proliferator-activated receptor-stimulated ex
300 rget soluble epoxide hydrolase (sEH) and the peroxisome proliferator-activated receptor type gamma (P
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。